-
Hainan Bite Voriconazole for Injection is approved for production and deemed to have been reviewed
Time of Update: 2022-05-24
In recent years, among the terminal systemic antifungal chemical products in China's public medical institutions, voriconazole for injection has ranked first.
-
Bristol-Myers Squibb's blockbuster immunotherapy combination receives FDA priority review
Time of Update: 2022-05-23
References:[1] US Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Chemotherapy as Neoadjuvant Treatment for Resectable Non-Small Cell Lung Cancer.
-
Dupixent receives FDA priority review and is expected to gain new indications
Time of Update: 2022-05-22
S. Food and Drug Administration (FDA) has granted priority review status for the supplemental biological product application (sBLA) of the blockbuster IL-4/IL-13 inhibitor Dupixent (dupilumab).
-
Innovative FGFR inhibitor for the treatment of cholangiocarcinoma was granted priority review by the FDA
Time of Update: 2022-05-22
S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for futibatinib for the treatment of locally advanced or metastatic cholangiocarcinoma harboring FGFR2 gene rearrangements (including gene fusions).
-
3rd review!
Time of Update: 2022-05-22
Sales of terminal midazolam injection in Chinese public medical institutions in recent years (unit: 100 million yuan)Source: Minet.
-
Zheng Chunfu/Gao Jie was invited to publish a cover review in Journal of Virology
Time of Update: 2022-05-21
Jie Gao of Inner Mongolia University were invited to publish a cover review in the Journal of Virology (JVI): When poly(A) binding proteins meetviral infections.
-
Nature Reviews Drug Discovery: Using NK Cells for Cancer Immunotherapy
Time of Update: 2022-05-21
Bispecific or specific antibodiesBispecific or specific antibodiesBispecific or trispecific antibodies can simultaneously bind to NK cell-activated receptors and tumor antigens, promoting more potent and durable NK-mediated cytotoxicity .
-
AstraZeneca/Daisankyo's blockbuster ADC for the treatment of non-small cell lung cancer received priority review
Time of Update: 2022-05-20
S. FDA for the treatment of patients with unresectable or metastatic non-small cell lung cancer (NSCLC) harboring HER2 mutations .
-
Pay attention to the dynamics of the consistency evaluation of generic drugs, which varieties have been reviewed recently?
Time of Update: 2022-05-20
/> The progress of drug review has always attracted the attention of the industry. What varieties have been reviewed recently? Peking University Pharmaceuticals: Compound Sulfamethoxazole Tablets Reviewed Peking
-
FDA grants priority review to Enhertu in lung cancer
Time of Update: 2022-05-20
The drug first received accelerated approval for HER2-positive unresectable or metastatic breast cancer in 2019 and FDA approval in 2021 for previously treated HER2-positive locally advanced orgastric cancer .
-
2 over 2 billion varieties of Sialon Pharmaceuticals were reviewed on the same day
Time of Update: 2022-05-20
Application of Consistency Evaluation of Tigecycline for Injection Source: Minet Consistency Evaluation Database Tigecycline for injection is planned to be included in the seventh batch of centralized procurement.
-
Professor Wang Pengfei's collaborative paper was published in Review of Economic Dynamics
Time of Update: 2022-05-20
, was officially published in the SSCI journal Review of Economic Dynamics (Volume 44, 2022, pp. 315-348) . The co-authors of the paper
-
The Ministry of Ecology and Environment reviewed 4 technical specifications including "Technical Specifications for Waste Plastic Pollution Control"
Time of Update: 2022-05-20
] On April 28, Huang Runqiu, Minister of the Ministry of Ecology and Environment, presided over an executive meeting of the Ministry to review and in principle undertake the approval of the "Issuance of the License for Marine Dumping of Waste
-
Systematic review and meta-analysis: external treatment of chemotherapy-induced peripheral neuropathy with Chinese herbal medicine
Time of Update: 2022-05-19
Traditional Chinese medicine treatment of CIPN has preventive and control effects by reducing the incidence of peripheral neurotoxicity, alleviating clinical symptoms, and improving quality of life.
-
Haisco Fat Emulsion Amino Acid (17) Glucose (11%) Injection Review
Time of Update: 2022-05-19
On April 19, Haisco announced that the company's subsidiary, Liaoning Haisco Pharmaceuticals Fat Emulsion Amino Acid (17) Glucose (11%) Injection passed the quality and efficacy consistency evaluation of generic drugs .
-
The first review!
Time of Update: 2022-05-19
hospital hospital hospital Sales of terminal piracetam injections in Chinese public medical institutions (unit: 10,000 yuan) Source: Minet.
-
100 million-level best-selling cardiovascular drug Chengdu Bitedigoxin Tablets is the first to review
Time of Update: 2022-05-18
On April 19, NMPA's official website released the latest information on approved drugs, and Chengdu Beite Pharmaceutical's digoxin tablets were the first to be reviewed .
-
Recently, local pharmaceutical companies have successively reviewed a number of large varieties of drugs
Time of Update: 2022-05-18
Data shows that in 2020, the market size of the terminal piracetam injection in China's public medical institutions is close to 2 billion yuan, a year-on-year increase of 37.
-
, together with the teams from Xi'an Jiaotong University and the University of Macau, published a review of the frontiers of treatment strategies for IBD
Time of Update: 2022-05-17
of Macau, published a review of the frontiers of IBD treatment strategies in the famous pharmacological journal "Pharmacological Research" . >>Inflammatory bowel disease (IBD
-
Sinopharm Yixin Cytarabine for Injection to be included in priority review
Time of Update: 2022-05-17
It is also a functional general-purpose cancer treatment drug, such as cytarabine combined with anthracyclines for the treatment of acute myeloid leukemia and lymphoma, etc.
